How have IPA shares performed in 2024?

ImmunoPrecise Antibodies' stock was trading at C$6.50 at the start of the year. Since then, IPA stock has increased by 0.0% and is now trading at C$6.50. View the best growth stocks for 2024 here .

What other stocks do shareholders of ImmunoPrecise Antibodies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ImmunoPrecise Antibodies investors own include Alimentation Couche-Tard (ATD.B) , Brookfield Renewable Partners (BEP.UN) , Brookfield Infrastructure Partners (BIP.UN) , Canadian Utilities (CU) , Enghouse Systems (ENGH) , Intact Financial (IFC) , Metro (MRU) , Northwest Pipe (NWPX) , TrueContext (PFM) and Royal Bank of Canada (RY) .

How do I buy shares of ImmunoPrecise Antibodies?

Shares of IPA stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor , Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. Compare Top Brokerages Here .

CVE:IPA

ImmunoPrecise Antibodies (IPA) Stock Price, News & Analysis

→ A new way to collect income from stocks (From DTI) (Ad)

Free IPA Stock Alerts

C$6.50

+0.05 (+0.78%)

(As of 11/25/2022)

Compare

Today's Range: C$6.19
▼
C$6.70
50-Day Range: C$6.50
▼
C$6.50
52-Week Range: C$4.52
▼
C$8.81

Volume: 19,980 shs
Average Volume: 19,376 shs
Market Capitalization: C$162.08 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get ImmunoPrecise Antibodies alerts:

Ad Paradigm Press

AI “wealth window” is closing soon!

Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.

I put together this personal video [HERE]…

About ImmunoPrecise Antibodies

ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth factors, and hybridoma products for research purposes. Its contract research organization services include custom antigen modeling, design, and manufacturing; B cell sorting, screening, and sequencing; custom, immune, and naive phage display production and screening; transgenic animals and multi-species antibody discovery; bi-specific, tri-specific, VHH, and VNAR (shark) antibody manufacturing; DNA cloning, protein and antibody downstream processing; antibody characterization on label-free biosensors and antibody engineering; transient and stable cell line generation; antibody optimization and humanization; hybridoma production with multiplexed, high-throughput screening, and clone-picking; and cryopreservation. The company has research collaboration agreements with Pierre Fabre S.A for antibody discovery; and Elektrofi, Inc. to explore a high-concentration formulation of COVID-19 antibody cocktail, PolyTope TATX-03. ImmunoPrecise Antibodies Ltd. was incorporated in 1983 and is based in Victoria, Canada.

IPA Stock Price History

30 days | 90 days | 365 days | Advanced Chart

IPA Stock News Headlines

March 14, 2024 | finance.yahoo.com

IPA Reports Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2024*

December 7, 2023 | finanznachrichten.de

ImmunoPrecise Antibodies Ltd.: ImmunoPrecise Antibodies Welcomes Mitch Levine To Its Board Of Directors, To Announce Quarterly Results On December 14

April 17, 2024 | Priority Gold (Ad)

Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!

Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.

November 13, 2023 | benzinga.com

BioStrand® Unveils a Revolutionary Approach to Biological Sequence Retrieval: A Fusion of Natural Language Processing and Database Research

November 13, 2023 | msn.com

EXCLUSIVE: Antibody-Discovery Platform Provider ImmunoPrecise's Subsidiary Highlights Approach to Biological Sequence Retrieval

October 23, 2023 | finance.yahoo.com

IPA Provides Update on Growth Strategy and Recent Share Price Movement

October 11, 2023 | finance.yahoo.com

ImmunoPrecise Antibodies Ltd. (IPA) Could Find a Support Soon, Here's Why You Should Buy the Stock Now

August 26, 2023 | finance.yahoo.com

ImmunoPrecise Antibodies Ltd. (TQB.F)

April 17, 2024 | Priority Gold (Ad)

Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!

Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.

July 13, 2023 | finance.yahoo.com

ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q4 2023 Earnings Call Transcript

July 12, 2023 | msn.com

Benchmark Reiterates ImmunoPrecise Antibodies (IPA) Speculative Buy Recommendation

May 17, 2023 | benzinga.com

ImmunoPrecise Antibodies Stock (NASDAQ:IPA), Guidance and Forecast

March 21, 2023 | hk.finance.yahoo.com

ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q3 2023 Earnings Call Transcript

March 16, 2023 | finance.yahoo.com

ImmunoPrecise Antibodies Ltd. (IPA) Reports Q3 Loss, Lags Revenue Estimates

March 15, 2023 | msn.com

Earnings Outlook For ImmunoPrecise Antibodies

September 16, 2022 | finance.yahoo.com

Here's Why We're Watching ImmunoPrecise Antibodies' (CVE:IPA) Cash Burn Situation

September 16, 2022 | stockhouse.com

NIAID Confirms IPA's PolyTope TATX-03 Neutralizing Activity Against the Currently Spreading SARS-CoV-2 Variant BA.2.75

September 16, 2022 | seekingalpha.com

ImmunoPrecise Antibodies Ltd. (IPA) Q1 2023 Earnings Call Transcript

September 14, 2022 | nz.finance.yahoo.com

NIAID Confirms IPA’s PolyTope TATX-03 Neutralizing Activity Against the Currently Spreading SARS-CoV-2 Variant BA.2.75

August 30, 2022 | stockhouse.com

Live Virus Assays at Ludwig-Maximilians-Universität München Confirm PolyTope's Efficacy Against SARS-CoV-2 Variants Including BA.5

April 20, 2022 | seekingalpha.com

ImmunoPrecise antibody cocktail shows neutralizing activity versus Omicron BA.2 in lab test

March 17, 2022 | seekingalpha.com

ImmunoPrecise Antibodies reports Q3 results

December 20, 2021 | yahoo.com

ImmunoPrecise Antibodies and ChemPartner Biologics Announce PolyTope® TATX-03 Antibody Cocktail Manufacturing Collaboration

November 30, 2021 | finance.yahoo.com

ImmunoPrecise Update on its SARS-CoV-2 PolyTope™ Multi-Antibody Cocktail Development Program

September 7, 2021 | stockhouse.com

ImmunoPrecise Announces Participation at the H.C. Wainwright 23nd Annual Global Investment Conference on September 13-15, 2021 (Virtual Conference)

August 4, 2021 | benzinga.com

Unusual Options Activity Insight: ImmunoPrecise Antibodies

July 28, 2021 | stockhouse.com

ImmunoPrecise Reports Financial Results and Recent Business Highlights for Full Fiscal Year 2021

See More Headlines

Receive IPA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ImmunoPrecise Antibodies and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: CVE
Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Current Symbol: CVE:IPA
CUSIP: N/A
CIK: N/A
Web: immunoprecise.com
Phone: +1-604-8060626
Fax: N/A
Employees: 73
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: 1.70
Current Ratio: 5.06
Quick Ratio: 4.29

Sales & Book Value

Annual Sales: C$19.47 million
Price / Sales: 8.33
Cash Flow: C$0.77 per share
Price / Cash Flow: 8.39
Book Value: C$2.67 per share
Price / Book: 2.44

Miscellaneous

Outstanding Shares: 24,935,000
Free Float: N/A
Market Cap: C$162.08 million
Optionable: Not Optionable
Beta: N/A

10 Best Cheap Stocks to Buy Now

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

Dr. Jennifer Lynne Bath Ph.D.
CEO, Pres & Non-Independent Director
Mr. Brad McConn
Chief Financial Officer
Dr. Ilse Roodink
Chief Scientific Officer
Mr. David E. Orton
Chief Operating Officer
Ms. Carla Dahl
VP of Marketing
Dr. Barry Neil Duplantis
VP of Client Relations

Key Competitors

View All Competitors

IPA Stock Analysis - Frequently Asked Questions

How have IPA shares performed in 2024?: ImmunoPrecise Antibodies' stock was trading at C$6.50 at the start of the year. Since then, IPA stock has increased by 0.0% and is now trading at C$6.50.
View the best growth stocks for 2024 here.
What other stocks do shareholders of ImmunoPrecise Antibodies own?: Based on aggregate information from My MarketBeat watchlists, some companies that other ImmunoPrecise Antibodies investors own include Alimentation Couche-Tard (ATD.B), Brookfield Renewable Partners (BEP.UN), Brookfield Infrastructure Partners (BIP.UN), Canadian Utilities (CU), Enghouse Systems (ENGH), Intact Financial (IFC), Metro (MRU), Northwest Pipe (NWPX), TrueContext (PFM) and Royal Bank of Canada (RY).
How do I buy shares of ImmunoPrecise Antibodies?: Shares of IPA stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (CVE:IPA) was last updated on 4/17/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial